Feeds:
Posts
Comments

Posts Tagged ‘negotiating’

Securing an investor is an important aspect of growing your business. For early stage companies seeking financing, the term sheet will outline the key terms of the proposed investment. Sharing company equity with a VC is a negotiable challenge. In this seminar, the panelist will outline the basics of terms sheets, and share best practices with entrepreneur when it comes to negotiating a term sheet.

Join us for Term Sheets – Negotiating the Perfect Deal at our “Growing Your Business” breakfast event series 7:30 to 10 a.m., Thursday,  May 12 at the University of Toronto Mississauga’s Faculty Club

Guest Speakers:

Eric R. Klein, Partner, Farber Financial Group  is the Leader of Klein Farber, the Corporate Finance & Transactions practice of Farber Financial Group. Eric’s practice focuses on providing value-added financial advisory services to mid-market companies. Eric focuses on complex mergers, acquisitions, divestitures, business valuations, strategic partnerships, exit and succession planning, and financings as well as joint ventures of mid-sized Canadian corporations. A consummate negotiator, Eric works with all parties to obtain the best possible outcome for his clients in transactions. He is a frequent lecturer and speaker on corporate finance and entrepreneurship and is involved in various charities.

David Pamenter, Partner, Gowlings,  is the National Leader of Gowlings Technology Industry Group and specializes in business law and practices in the Toronto office. He has more than thirty years of experience in private financings (including venture capital financings), M&A and technology licensing. He advises a wide spectrum of domestic and international clients on matters of both a day-to-day and a strategic nature. David has represented clients on a diverse range of transactions including commercialization of intellectual property. David is active in the Intellectual Property, International Law and Small Business Committees of the Section of Business Law of the ABA.

Paul Chipperton, CEO and Co-founder, Profound Medical Inc.,  is responsible for all aspects of the corporate and operational advancement of the company. He has significant successful international biotech “start-up” and New Product Development (NPD) management experience, and has previously led Business Development & Marketing with a number of companies, most notably CRi & Beckman-Coulter, PerkinElmer, and DNAGenotek. He is also a co-founder and Board member of InDanio Bioscience Inc, and a guest lecturer at both McGill University and University of Toronto on managing innovation and entrepreneurship in the Life Science sector.

The Research Innovation Commercialization (RIC) Centre hosts the 10-event series, which runs from September to June 2011. Gowlings is the session sponsor.

For a complete schedule visit riccentre.com

Pre-Registration $25, Pay at Event $30 (covers breakfast and parking). To register, visit www.riccentre.com.

For more information, contact Jasmeet at  289-373-3050 or by email at jasmeet@riccentre.com

The RIC blog is designed as a showcase for entrepreneurs and innovation. Our guest bloggers provide a wealth of information based on their personal experiences. Visit RIC Centre for more information on how RIC can accelerate your ideas to market.

Add to FacebookAdd to DiggAdd to Del.icio.usAdd to StumbleuponAdd to RedditAdd to BlinklistAdd to TwitterAdd to TechnoratiAdd to FurlAdd to Newsvine

Read Full Post »